ID   SUP-T2
AC   CVCL_F693
SY   Stanford University Pediatric T-cell line 2
DR   Wikidata; Q54970897
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3004618;
RX   PubMed=6437672;
CC   Doubling time: 130 hours (PubMed=3004618).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=3004618; DOI=10.1182/blood.V67.3.650.650;
RA   Smith S.D., Morgan R., Link M.P., McFall P., Hecht F.;
RT   "Cytogenetic and immunophenotypic analysis of cell lines established
RT   from patients with T cell leukemia/lymphoma.";
RL   Blood 67:650-656(1986).
//
RX   PubMed=6437672;
RA   Smith S.D., Shatsky M., Cohen P.S., Warnke R.A., Link M.P., Glader B.E.;
RT   "Monoclonal antibody and enzymatic profiles of human malignant
RT   T-lymphoid cells and derived cell lines.";
RL   Cancer Res. 44:5657-5660(1984).
//